HemoCue AB Box 1204 262 23 Ängelholm SWEDEN   Phone: +46 77 570 02 10 Fax: +46 77 570 02 12 E-mail: info@hemocue.se    Contact in your country    Printer friendly	Anemia is a common complication of diabetes and many individuals suffer from it's symptoms like fatigue and inactivity. It often goes undiagnosed and untreated even though it may be one of the earliest signs of renal disease. Anemia seriously destabilizes not only a patient's health but also diminishes the quality of that person's life. Using HemoCue Hemoglobin systems at the point of care is a quick and easy way to identify individuals at risk, allowing for immediate action and subsequent treatment.       The HemoCue Glucose systems are perfect tools for diabetes professionals. In three simple steps, the system gives glucose values that can be used for:    • Diagnosing diabetes mellitus    • Screening for gestational diabetes    • Performing oral glucose tolerance tests    • Clamp studies    • Verifying patient test strip meters   People with diabetes are at higher risk of developing micro and macrovascular complications in comparison with healthy subjects. Microalbuminuria is the earliest sign of renal dysfunction and an indication of disease progression. Multiple studies conclude that the presence of persistent microalbuminuria strongly predicts those who will eventually develop diabetic nephropathy. Patients with a persistent microalbuminuria have a twenty-fold increased risk of developing diabetic nephropathy and international guidelines recommends annual screening for microalbuminuria for early determination as to which patients require intervention.   Read more in our brochure on Diabetes care: Three vital tests in Diabetes Care